HighTower Advisors’s Traws Pharma TRAW Stock Holding History

HighTower Advisors’s Portfolio TRAW Stock Details TRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Hold	0	–	-$11K	–	2052
2016 Q1	–	Hold	0	–	–	–	2044
2015 Q4	–	Hold	0	–	–	–	1958
2015 Q3	–	Hold	0	–	–	–	1810
2015 Q2	–	Hold	0	–	–	–	1452
2015 Q1	–	Hold	0	–	–	–	1549
2014 Q4	–	Sell	-1	Closed	-$245K	–	1495
2014 Q3	$125K	Buy	+1	New	+$285K	﹤0.01%	1417
2014 Q2	–	Hold	0	–	–	–	1472
2014 Q1	–	Sell	-1	Closed	-$602K	–	1373
2013 Q4	$0	Buy	+1	New	+$947K	﹤0.01%	1615

Other funds holding TRAW

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

HighTower Advisors's TRAW Position: Q2 2016 in Review

HighTower Advisors held its Traws Pharma (TRAW) position steady in Q2 2016 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2052.

HighTower Advisors first reported a position in TRAW in Q4 2013 and has held it in 2 quarters since. The position peaked at $125K in Q3 2014. 4 funds tracked by Wall St. Rank hold TRAW as of Q2 2016.

HighTower Advisors held 0 shares of Traws Pharma worth $0 as of Q2 2016.
HighTower Advisors left its Traws Pharma share count unchanged in Q2 2016.
Traws Pharma made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2016, its #2052 holding.
HighTower Advisors first reported a position in Traws Pharma in Q4 2013 and has held it in 2 quarters since.
HighTower Advisors's Traws Pharma position peaked at $125K in Q3 2014.
4 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2016.

Based on HighTower Advisors's 13F filing for Q2 2016, filed 11 Aug 2016.